Rapport Therapeutics, Inc. Common Stock
$33.91
▲ +0.08
(+0.24%)
Volume: 711,629
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -35.4%
- MA aligned bearish
- RSI 25 oversold
🎯
Pullback
71
- RSI 25 near lows
- Near lower Bollinger band
- -21.0% vs 20MA
💎
Value
58
- -36% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)25.3
MACD-1
MA trendBearish
ATR7.81%
21d mom.-35.4%
63d mom.-15.3%
vs 20MA-21.0%
RVOL(20)1.63×
52w low · 24
52w high · 53
-35.9% from 52-week high
20d support 32
· resistance 51
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$1.6B
PER—
PBR3.84
PSR81.16
EPS$-2.86
ROE-32.4%
ROA-29.9%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-10.22
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -16.17% | -35.41% | -15.35% | +16.93% | +25.78% | +20.63% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -25.91%, daily vol 3.94%. Rapport Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.